Mississippi State University

Scholars Junction
Theses and Dissertations

Theses and Dissertations

8-10-2018

Effects of Dietary Supplementation of L-Methionine vs DlMethionine on Performance, Plasma Concentrations of Free
Amino Acids and Other Metabolites, and Myogenesis Gene
Expression in Young Growing Pigs
Zhongyue Yang

Follow this and additional works at: https://scholarsjunction.msstate.edu/td

Recommended Citation
Yang, Zhongyue, "Effects of Dietary Supplementation of L-Methionine vs Dl-Methionine on Performance,
Plasma Concentrations of Free Amino Acids and Other Metabolites, and Myogenesis Gene Expression in
Young Growing Pigs" (2018). Theses and Dissertations. 1735.
https://scholarsjunction.msstate.edu/td/1735

This Graduate Thesis - Open Access is brought to you for free and open access by the Theses and Dissertations at
Scholars Junction. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of
Scholars Junction. For more information, please contact scholcomm@msstate.libanswers.com.

Template C v3.0 (beta): Created by J. Nail 06/2015

Effects of dietary supplementation of L-methionine vs DL-methionine on performance,
plasma concentrations of free amino acids and other metabolites, and myogenesis gene
expression in young growing pigs

By
TITLE PAGE
Zhongyue Yang

A Thesis
Submitted to the Faculty of
Mississippi State University
in Partial Fulfillment of the Requirements
for the Degree of Master of Science
in Agriculture
in the Department of Animal and Dairy Sciences
Mississippi State, Mississippi
August 2018

Copyright by
COPYRIGHT PAGE
Zhongyue Yang
2018

Effects of dietary supplementation of L-methionine vs DL-methionine on performance,
plasma concentrations of free amino acids and other metabolites, and myogenesis gene
expression in young growing pigs
By
APPROVAL PAGE
Zhongyue Yang
Approved:
____________________________________
Shengfa Liao
(Major Professor)
____________________________________
Mark Crenshaw
(Committee Member)
____________________________________
Derris Burnett
(Committee Member)
____________________________________
Jamie Larson
(Graduate Coordinator)
____________________________________
John Blanton
(Head of Department of Animal and Dairy Sciences)
____________________________________
Geroge M. Hopper
Dean
College of Agriculture and Life Sciences

Name: Zhongyue Yang
ABSTRACT
Date of Degree: August 10, 2018
Institution: Mississippi State University
Major Field: Agriculture
Major Professor: Shengfa Liao
Title of Study: Effects of dietary supplementation of L-methionine vs DL-methionine on
performance, plasma concentrations of free amino acids and other
metabolites, and myogenesis gene expression in young growing pigs
Pages in Study 70
Candidate for Degree of Master of Science
This research was conducted to study the effects of supplemental L-Methionine
(L-Met) and DL-Methionine (DL-Met) on nutrient metabolism, muscle gene expression,
and growth performance of pigs. Twenty crossbred young barrows (initial Body Weight
(BW) 21.2 ± 2.7 kg) were randomly assigned to 2 treatments. Crystalline L-Met and DLMet were supplemented to the diets in Treatment 1 and 2 (both at 0.13%, as-fed basis),
respectively. After 4 weeks of an ad libitum feeding trial, BW and feed intake were
measured to calculate Average Daily Gain, Average Daily Feed Intake, and Gain: Feed.
The blood samples were collected from the jugular vein for analyses of plasma AA and
metabolite concentrations. The longissimus dorsi muscle samples were collected for
analysis of myogenesis gene expression. The findings from this study (from gene
expression to animal growth performance) suggest that the bioefficacy of L-Met is the
same as for DL-Met, indicating the highly efficient conversion of D-Met to L-Met in
young growing barrows.
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METHIONINE NUTRITION IN SWINE AND OTHER MONOGASTRIC ANIMALS:
PROTEIN BIOSYNTHESIS AND BEYOND: A REVIEW
1.1

Introduction
Swine is one of the most economical livestock species that provides pork, an

excellent source of dietary protein for human consumption (Wu et al., 2014; Hou et al.,
2015; Liao et al., 2015). The predominant tissue component of pork or pork products is
skeletal muscle, and in modern swine industry, the efficiency of pork production is
measured by the efficiency of lean gain (i.e., the muscle gain) rather than the whole body
weight gain (McGlone and Pond, 2003; Liao et al., 2015). Hence, the knowledge
concerning the growth and development of skeletal muscle of the pig is crucial from both
economic and technical standpoints.
Skeletal muscle, as the most abundant tissue in pig body, accounts for 20 to 50%
of the total body mass, exhibiting major metabolic activities by contributing up to 40% of
the resting metabolic rate (in adult pigs) and serving as the largest pool of body proteins
(Liao et al., 2015; Bell et al., 2016; Li et al., 2016). Proteins, as the major chemical
component of skeletal muscle, are synthesized from L-a-amino acids (AAs), which
originate from dietary protein source including supplemented AAs (O'Connor et al.,
2003; Wu, 2013; Li et al., 2016). There are 20 AAs in nature that serve as building blocks
for protein synthesis and, therefore, are called proteinogenic AAs. Ten of the
1

proteinogenic AAs are dietary essential AAs for pigs (NRC, 2012; Liao et al. 2015).
Methionine (Met), also known as 2-amino-4-methylthio butanoic acid (Figure 1.4), is the
second or third limiting essential AA in typical grain-based swine diets (NRC, 2012; Wu,
2013; Shen et al., 2014) and, thus, dietary supplementation of crystalline Met is necessary
for the optimal growth of pigs.
Previous researcheres have reported that dietary supplementation of Met can
increase nitrogen retention and muscle protein accretion in pigs via increasing protein
synthesis and decreasing protein degradation and, therefore, the growth performance of
pigs (Chung and Baker, 1992a; Zimmermann et al., 2005; Kim et al., 2006; Wen et al.,
2014; Kong et al., 2016a,b). In addition to protein synthesis, Met is also involved in
various other important metabolic functions, such as serving as a methyl donor for DNA
methylation and polyamine synthesis (Grimble, 2002), a regulator of animal immune
function (Capozzalo et al., 2017), and a precursor for synthesis of glutathione (GSH) via
cysteine (Cys) synthesis (Wu et al., 2004). Nevertheless, the underlying metabolic and
molecular mechanisms by which dietary Met regulates pigs’ metabolic and physiological
functions warrant further investigation (Wu, 2010; Rezaei et al., 2013). The aim of this
review is to summarize the updated knowledge concerning the metabolic and
physiological functions of Met responsible for the growth and development of pigs. It
needs to be pointed out that some knowledge discussed in this review was appropriated
from the research on other animals (including humans) when the swine-related research is
lacking.

2

1.2

Forms of Feed-Grade Methionine Products
Except for glycine, the simplest AA in nature, all proteinogenic AAs having at

least one asymmetric carbon exhibit optical activity or rotatory polarization (Wu, 2013),
which means when a beam of plane-polarized light is passed through a solution of an
optical isomer the light will be rotated to either the left (levo- or L-form) or the right
(dextro- or D-form). In other words, the corresponding L- and D-AAs are symmetrical
with a mirror, which is termed as a chirality phenomenon in chemistry. When equal
amounts of L- and D-AAs are present, the resulted mixture will have no optical activity
(Wu, 2013). The L-AAs are the predominant isomers in nature; however, some D-AAs
also exist in animals, plants, and microorganisms (Friedman, 1999; Wu, 2013).
Almost all AAs (except for glycine) in living organisms have two possible
configurations (L- vs. D-isomer), and the absolute configuration of an AA is defined
arbitrarily with reference to glyceraldehyde (Wu, 2013). The metabolic utilization of Disomers of AAs by animals depends on whether or not the D-AAs can be efficiently
transformed to their L-isomers.
As to D- and L-Met, the only difference between the two is between the two blue
chemical bonds as shown in Figure 1.1 L-Met can be used directly by animals for
metabolism and protein synthesis (Dibner and Ivey, 1992; Stoll et al., 1998; MartínVenegas et al., 2006; Willke, 2014; Tian et al., 2016; Kong et al., 2016a), but D-Met
needs to be converted to L-Met (following the pathways shown in Figure 1.2) before
being used by the animal (Dibner, 2003). Due to the existence of substantial D-AA
oxidase activity in various tissues (Brachet and Puigserver, 1992), it is thought that DMet can be readily converted to L-Met by pigs (Wretlind and Rose, 1950; Cho and
3

Stegink, 1979; Sugiyama and Muramatsu, 1987; Hasegawa et al., 2005; Kong et al.,
2016b).
The most popular form of commercial products of feed Met is DL-Met that
consists of 50% D-Met and 50% L-Met. The DL-Met products were produced by a few
German, American, and Japanese companies, after Met was initially synthesized
successfully by AEC (later, changed to Adisseo) in France in 1945. In 1946, Werner
Schwarze working for Degussa, a predecessor company of Evonik, developed a
technically feasible method for synthesizing DL-Met which led to the construction of the
first DL-Met plant (360 tons/year) in the world in 1948 (Willke, 2014).
Another popular form of commercial product is a Met hydroxyl analogue,
chemically termed 2-hydroxy-4-methylthio butanoic acid (HMTBA or HMB). Similar to
DL-Met, HMTBA also occurs as a mixture of L-HMTBA and D-HMTBA isomers
because of the existence of one asymmetrical carbon atom in its structure. As a keto acid,
HMTBA products are in liquid form and usually consist of 12% water and 88% HMTBA
molecules, of which nearby 65% is present in monomer form. There is also a solid form
of Met hydroxyl analogue that is the calcium salt of DL-Met hydroxyl analogue, which
contains 84% of effective substance and 12% calcium (Adisseo, 2013). The products of
Met hydroxyl analogue have also been widely used in diets for poultry, swine and
ruminants (Dibner, 2003; Ma et al., 2013).
HMTBA is actually an organic acid, since a hydroxyl group is replaced by an
amino group found in Met molecule (Dibner, 2003; Ma et al., 2013). To be utilized by
animal tissues for protein synthesis, both the D- and the L-isomers of HMTBA products
have to be converted to L-Met via transamination whereas only the D-isomer in DL-Met
4

needs to be transformed (Figure 1.2). The conversion of HMTBA to L-Met within animal
tissues can occur through broadly distributed enzymatic systems, and the incorporation
studies indicated that both D- and L-isomers of HMTBA are converted to L-Met at rates
similar to the D-stereoisomer in DL-Met (Dibner and Knight, 1984; Dibner, 2003).
Compared to the DL-Met and DL-HMTBA products, the commercial L-Met
products are less popular as animal feed supplement. L-Met was usually obtained by
purification of L-Met from a DL-Met product and was quite expensive and, thus, was
seldom used in animal feed industry. Recently, however, a feed-grade L-Met product
(90% purity) has become available on the market of some countries. The feed grade LMet is produced from either chemical synthesis or a process of bio-fermentation of plantbased raw materials (Willke, 2014). As a new form of commercial Met products, some
studies have been conducted to compare the effectiveness of L-Met on animals’ growth
and development relative to the aforementioned classical Met forms, such as DL-Met and
DL-HMTBA (Shen et al., 2014; Htoo and Morales, 2016; Tian et al., 2016; Kong et al.,
2016a,b; Li et al., 2017).
1.3

Effectiveness of Methionine on Swine Growth Performance
Since 1950s when DL-Met was successfully produced, the effectiveness of feed

Met on swine production performance has been investigated by numerous researchers.
The earliest study of the effects of DL-Met for farm animals was conducted in young
growing pigs (4 to 8 weeks of age) by Bell et al. (1950), who reported supplementation of
DL-Met to a soybean meal diet (up to 0.27%) improved the growth efficiency of the pigs
and that the biological values of the diet was equal to the values obtained from a diet
containing whole egg protein at 10%. Therefore, Met was then recognized as an essential
5

AA for the growth of young pigs (Bell et al., 1950; Becker et al., 1955). In the following
year, Shelton et al. (1951) studied the effect of Met and cystine on the growth of
weanling pigs, with which the Met requirement was set at 0.6% of the ration in the
absence of and at 0.3% of the ration in the presence of adequate cystine (0.3% or more).
Later, the dietary requirements of Met by pigs were further defined by other researchers
(Curtin et al., 1952; Becker et al., 1955; Keith et al., 1972; Balogun et al., 1981; Chung
and Baker, 1992a).
Bayley and Summers (1968) reported the supplementation of practical cornsoybean meal diets (containing 12 to 14% crude protein) with 0.05% Met for growing
pigs had no beneficial effect on growth rate or feed efficiency, but there was a positive
effect on gain when 0.1% lysine was added at the same time. However, Katz et al.
(1973) observed that addition of DL-Met to a lysine-supplemented corn-soybean meal
diet (containing 16% crude protein) did not further improve weight gain. Addition of
crystalline DL-Met to four basal diets for growing pigs resulted in significant
improvement in the rate and efficiency of gain at the 16 and 18% protein levels but not at
the 20 or 22% level (Fetuga et al., 1975). From the research results summarized above, it
can be concluded that the effectiveness of dietary Met supplementation on swine growth
performance depends on the crude protein content, as well as the lysine content of the
diet used.
The effectiveness of HMTBA vs. DL-Met on pigs’ growth has also been
evaluated in numerous studies. Several reports showed that the bioavailability of
HMTBA was lower than that of DL-Met (Roth and Kirchgessner, 1986; Zimmermann et
al., 2005; Kim et al., 2006; Shoveller et al., 2010; Opapeju et al., 2012), while the others
6

stated that HMTBA and DL-Met were equivalent in promoting the growth performance
of pigs (Reifsnyder et al., 1984; Chung and Baker, 1992a; Knight et al., 1998; Römer and
Abel, 1999). An independent meta-analysis was conducted by Jansman et al. (2003) from
the Netherlands. Based on the weight gain and feed conversion data from the literature,
they reported the average effectiveness of liquid HMTBA was about 72% relative to DLMet (on the weight/weight basis).
Before a feed-grade L-Met product was developed, the use of L-Met was
negligible in the feed industry. Cho et al. (1980) conducted the first study on miniature
pigs comparing the effectiveness of L-Met vs. DL-Met, and their results showed no
differences on growing performance and feed utilization between L-Met and DL-Met,
which was later supported by Chung and Baker (1992a). Reifsnyder et al. (1984),
however, showed that approximately 20% more DL-Met was required to achieve the
same feed efficiency as L-Met fed to 3-week-old pigs. As the commercial obtainability of
feed-grade L-Met increases, more research is expected to be conducted to study the
effectiveness of L-Met on pigs’ performance. Although Shen et al. (2014) showed that LMet had better effects than DL-Met on the growth performance and gut health of nursey
pigs, Htoo and Morales (2016) reported that L-Met and DL-Met had equal effects on the
growth performance of weaned pigs. Some other studies also demonstrated similar effects
between L-Met and DL-Met on nitrogen balance in nursery pigs (Kong et al., 2016a; Tian
et al., 2016). Currently, the feed-grade L-Met products are still new, more exploration on
the effectiveness of L-Met relative to other forms of Met products is still warranted.
Apparently, a defined conclusion about the effectiveness of different forms of
feed-grade Met products on pig’s growth performance cannot be easily drawn from the
7

available data reported in the literature. Several factors may contribute to the apparently
inconsistent results reported: (1) different products of Met isomers and analogs used, (2)
different Met deficiency status of the animals fed different basal diets, (3) the relative
amounts of different Met isomers and analogs supplemented (Mandal et al., 2004), (4)
different animal response criteria used, (5) different routes for delivering the test
compounds (Chung and Baker, 1992b), (6) the experimental animals different in age
and/or physiological state (Shen et al., 2014), and (7) different dietary content ratios of
Met to Cys and to other AAs (Mandal et al., 2004).
1.4

Intestinal Absorption of Methionine
Generally, there are three routes of dietary nutrient absorption or transport, which

are the transporter-mediated transcellular absorption, the tight junction associated paracellular absorption, and the clatharin- or receptor-mediated transcytosis (Wu, 2013).
Small peptides and free AAs in intestinal lumen are absorbed by the transporter-mediated
transcellular route, and there are several AA transporter systems critical for luminal AA
absorption into animal tissues (Bröer and Palacín, 2011). Within one system a couple of
transporters may transport same AAs, and one given transporter can transport multiple
AAs. Methionine can be transported by multiple transporters in animal cell membranes,
which are summarized in Table 1.1.
To be transferred from intestinal lumen into bloodstream, Met firstly enters
intestinal absorptive epithelial cells through the corresponding transporters presented in
the brush border membranes at the apical side, and then exports from the epithelial cells
(enterocytes) to the bloodstream through the transporters presented in the basolateral
membranes (Matthews, 2000). Figure 1.3 illustrates how L-Met is transported from
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intestinal lumen into bloodstream through one enterocyte. Soriano-Garcia et al. (1998)
once reported that L-Met is transported by four transport systems in chicken jejunum, one
(system a) with functional characteristics similar to those of system b0,+; a second
system (system b) similar to system y+; a third one (system c) that is Na+ independent
and has similar properties to system L; and a fourth system showing Na+ dependence and
tentatively identified with system B.
The efficiency of a given AA absorption hinges on the chemical nature of that AA
to be absorbed. As to D-Met, just like other D-AAs, the entry of D-Met into cells is the
first step in its metabolism. It appears that the transporters of L-Met can also transport DMet across the plasma and other biological membranes although these transporters
preferentially transport L-Met (Wu, 2013). In mammalian cells, the transport rate for DMet is lower than that for L-Met, and so is the affinity for D-Met (Wu, 2013). More
recently, Mastrototaro et al. (2017) reported that a diet containing DL-Met appears to
enhance L-Met and D-Met absorption in all the three segments of small intestine of
weaned pigs, which involves the induction of a Na+-dependent mechanism for L-Met
absorption in mid-jejunum.
The uptake of HMTBA across the brush border membrane are not the same way
as that of L-Met, since the chemical properties of HMTBA are fundamentally different
from that of L-Met. It is still not clear whether HMTBA is absorbed fully or after being
metabolized in the lumen (Dibner and Knight, 1984). Brachet and Puigserver (1987)
reported that the uptake HMTBA in rat jejunum is mediated by a Na+-independent
carrier system associated with L-lactate transport. Thus, it was suggested that this distinct
pathway could explain the lower biological utilization of HMTBA relative to DL-Met in
9

some animal species. Similarly, Maenz and Engele-Schaan (1996) showed in poultry that
L-Met and HMTBA are transported across the intestinal brush boarder membrane by two
different active transport mechanisms: L-Met is transported by a System B AAtransporter and its uptake is more efficient than that of HMTBA, while HMTBA is
transported by a H+-dependent non-stereospecific system. Maenz and Engele-Schaan
(1996) also reported that the affinity and maximal velocity of L-Met transport are greater
than that of HMTBA. All these results suggested that HMTBA is removed from the
intestinal lumen more slowly than L-Met, thus, has a greater exposure to intestinal
bacterial degradation, which may result in a lower amount of HMTBA available for
absorption (Malik et al., 2009).
1.5

Cellular Metabolism of Methionine
From either the structural or the metabolic standpoint, Met absorbed form dietary

source plays a key role in the cellular metabolism of sulfur-containing AAs, including
Met, Cys, homocysteine, and taurine. Cysteine directly participates in protein synthesis,
but homocysteine and taurine are metabolic intermediates in Met and Cys catabolism,
respectively (Brosnan and Brosnan, 2006; Brosnan et al., 2007; Riedijk et al., 2007).
Methyl group is covalently bound to sulfur atom in Met molecule (Figure 1.4), and the
sulfur atom is a crucial regulator of its structural and metabolic functions (Brosnan et al.,
2007). Based on the reaction types, Met metabolism can be described as
transmethylation, remethylation, and transsulfuration pathways (Brosnan and Brosnan,
2006; Riedijk et al., 2007; Brosnan et al., 2007). The major pathway is the intracellular
Met transmethylation via S-adenosyl-methionine (SAM) to produce homocysteine that
ubiquitously exists in various cells (Figure 1.5). Homocysteine is further catabolized to
10

synthesize Cys through transsulfuration pathway or to resynthesize Met through
remethylation pathway (Brosnan and Brosnan, 2006; Brosnan et al., 2007; Riedijk et al.,
2007). The transsulfuration pathway has a very limited tissue distribution, being highly
active in liver, kidneys, small intestine, and pancreas (Brosnan and Brosnan, 2006;
Brosnan et al., 2007). Among all tissues, the gastrointestinal tract is a metabolically
significant site of Met metabolism in the body (Bauchart-Thevret et al., 2009), and
studies in neonate pigs indicate the gastrointestinal tract metabolizes 20% of dietary Met
or other forms of feed Met (e.g., HMTBA) through transmethylation and transsulfuration
(Riedijk et al., 2007; Bauchart-Thevret et al., 2009).
1.5.1

Conversion of D-methionine and DL-2-hydroxy-4-methylthio butanoic
acid to L-methionine
Upon intestinal absorption, all D-Met and DL-HMTBA must be converted to L-

Met before their effective utilization by animal cells, whereas only the D-isomer in DLMet products need to be transformed to L-Met. The conversion of D-Met to L-Met
(Figure 1.2) involves two steps of chemical reaction (Sugiyama and Muramatsu, 1987).
In cellular peroxisomes, the D-AA oxidase (D-AAOX) converts D-Met to 2-keto-4(methylthio) butyric acid (KMB), an a-keto-acid, by oxidative deamination. This
conversion of D-Met to KMB is not a limiting factor due to the existence of substantial
D-AAOX activity in various tissues (Brachet and Puigserver, 1992; Fang et al., 2010).
Subsequently, various transaminases catalyze the conversion of these a-keto-acids into
the corresponding L-a-AAs. In addition, the bacteria in small intestinal lumen express
both D-Met oxidases and L-Met transaminases, which can convert D-Met to L-Met.
Notably, in contrast to animal cells, bacteria possess D-Met transaminases to produce a11

keto-acids from D-Met. These a-keto-acids are transaminated by L-AA transaminases to
generate new L-a-AAs. Thus, most animals including pigs and poultry can readily
convert D-Met to L-Met (Wu, 2013).
The conversion of synthetic HMTBA to the biologically active Met involves 2
enzymatic steps: oxidation of the α-carbon followed by transamination. The first step is a
stereospecific oxidation involving two enzymes: peroxisomal L-2-hydroxy acid oxidase
and mitochondrial D-2-hydroxy acid dehydrogenase. The specific enzyme L-2-hydroxy
acid oxidase has been found in chicken liver and kidney (Dibner, 2003), whereas D-2hydroxy acid dehydrogenase has been detected in numerous tissues, including liver,
kidney, muscle, intestine, spleen, and brain of chicken (Dibner and Knight, 1984). These
two enzymes catalyze the oxidation of L-HMTBA and D-HMTBA, respectively (Dibner
and Knight, 1984), yielding the corresponding α-keto acid (i.e., KMB) and hydrogen
peroxide. After formation of the common intermediate KMB, the second step is its
conversion to L-Met by transamination, which is ubiquitous and does not constitute a
limiting step in the complete conversion process (Dibner and Knight, 1984; Rangel-Lugo
and Austic, 1998).
Liver accounts for the majority of total body conversion of HMTBA to L-Met, the
kidney and small intestine, among other tissues, also substantially participate in the
HMTBA conversion (Laner, 1965; Martín-Venegas et al., 2006). It has been well
established that HMTBA can effectively replace Met as a dietary supplement for
chickens and rats (Laner, 1965). Piglets also had a substantial capacity to efficiently
utilize Met precursors; however, the extent to which Met precursors can be converted was
different among tissues (Fang et al., 2010). On the basis of the activity distribution and
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mRNA abundance of the enzymes oxidizing Met sources to KMB, the liver and kidney
are the major sites for conversion of the supplemented sources, and the stomach also
plays an important role in the HMTBA conversion (Fang et al., 2010). The intestine
contains a relatively higher capacity to convert D-Met than to convert HMTBA (Fang et
al., 2010). Okuno et al. (1989) suggested that the poor utilization of the dimers and
oligomers (i.e., 23% out of 88% active substance of HMTBA) is one of the main reasons
for lower effectiveness of HMTBA relative to DL-Met. Nevertheless, the stomach
contains a higher capacity to convert HMTBA than to convert D-Met (Fang et al., 2010).
1.5.2

Transmethylation and remethylation of L-methionine
L-methionine metabolism begins with the generation of a key intermediate, SAM,

by Met adenosyltransferase (Brosnan and Brosnan, 2006; Martín-Venegas et al., 2006;
Brosnan et al., 2007; Martinov et al., 2010). This reaction is unusual in that all 3
phosphates are removed from ATP (Figure 1.5), an indication of the “high energy” nature
of this sulfonium ion (Brosnan and Brosnan, 2006). SAM is also an important methyl
donor for most biological methylation reactions (Kano et al., 1982; Finkelstein, 1990;
Riedijk et al., 2007; Martinov et al., 2010; Wu et al., 2012; Jankowski et al., 2016). SAM
is catalyzed to produce S-adenosylhomocysteine (SAH) by methyltransferases (Brosnan
and Brosnan, 2006; Brosnan et al., 2007). Then SAH is hydrolyzed to homocysteine and
adenosine by SAH hydrolase and adenosylhomocysteinase. The later reaction is
reversible, and the thermodynamics favors SAH synthesis (Finkelstein, 1990). In vivo,
the reaction proceeds in the direction of hydrolysis only if the products, adenosine and
homocysteine, are metabolized (Finkelstein, 1990). This sequence of reactions is referred
to as transmethylation and is ubiquitously presented in cells (Brosnan and Brosnan,
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2006). Homocysteine may be methylated back to Met in the presence of vitamin B12
(Medici and Halsted, 2013), when receiving a methyl group from folate or betaine. Both
the ubiquitously distributed Met synthase and the betaine : homocysteine
methyltransferase (BHMT) in liver and kidney of some species are responsible for this
remethylation step (Brosnan and Brosnan, 2006; Grimble, 2006). Met synthase employs
5-methyl-THF as its methyl donor, whereas the betaine : homocysteine methyltransferase
employs betaine, which is produced during choline oxidation or provided from the diet
(Brosnan and Brosnan, 2006). The combination of transmethylation and remethylation is
commonly called Met cycle which occurs in most, if not all, cells (Brosnan and Brosnan,
2006).
1.5.3

Transsulfuration of L-methionine
The L-methionine catabolism is brought about by the transsulfuration pathway

(Figure 1.5), which converts homocysteine to Cys in two steps. The condensation of
homocysteine with serine produces cystathionine, catalyzed by cystationine b-synthase.
Cystathionine is then cleaved to Cys, a-ketobutyrate, and ammonia, which is catalyzed
by cystathionine g-lyase. This conversion of Met to Cys is an irreversible process, which
accounts for the well-known nutritional principle: Cys is not a dietary essential AA
provided that adequate Met is available, but Cys intake cannot remedy Met deficit
(Brosnan and Brosnan, 2006; Brosnan et al., 2007; Wu, 2013).
In addition to its function in L-Met catabolism, the transsulfuration pathway also
plays a particularly role in providing Cys for GSH synthesis (Beatty and Reed, 1980;
Brosnan and Brosnan, 2006; Brosnan et al., 2007). Cysteine availability is often limiting
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for GSH synthesis, and it appears that in a number of cells (e.g., hepatocytes), at least
half of the Cys required is provided by transsulfuration (Mosharov et al., 2000).
1.5.4

Transamination of L-methionine
The combined transmethylation and transsulfuration pathways are responsible for

the catabolism of a great portion of Met. However, there is also evidence for the
occurrence of a SAM- independent alternative pathway that begins with transamination.
This is a minor pathway under normal circumstances, but it could become more
significant when Met concentration is high (Brosnan and Brosnan, 2006). In 1978, based
on the detection of Met transamination in the homogenates of rat skeletal muscle, liver,
small intestine, and other tissues, Mitchell and Benevenga (1978) proposed this pathway.
Their studies were performed in the presence of very high concentrations of Met (10 to
20 mM) and the absence of other AAs. Since branched-chain AAs at physiological level
can essentially block this Met transamination in the skeletal muscle from rats and chicks,
this pathway is considered as a minor pathway of Met degradation under normal
circumstances (Scislowski and Pickard, 1994; Wu, 2013).
1.5.5

Use of L-methionine as an energy source
Like carbohydrates and lipids, AAs can also be used to meet animal energy

requirement, especially when carbohydrates and lipids become unavailable for providing
enough energy (Liao et al., 2015). In three metabolic circumstances, free AAs will
undergo post-absorptive oxidation to provide animal with energy: First, when a diet is
rich in protein and the released AAs exceed the body’s need for protein syntheses, the
surplus AAs are oxidized to ammonia and carbon dioxide via the formation of keto acid
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that will enter the tricarboxylic acid cycle to produce energy. The glucogenic AAs can
also provide energy through gluconeogenesis pathway. Secondly, there is a constant
protein turnover in virtually all living cells, and based on its own AA composition each
protein requires a certain ratio of free AAs. At a given time, the cellular free AA ratio
may not match the cellular requirements for syntheses of new proteins. Furthermore,
most cells or tissues unfortunately do not have a mechanism to store free AAs (Liao et
al., 2018). The “extra” free AAs can be metabolized to other biologically active
substances or catabolized to produce energy according to the dynamic needs and
metabolic potentials of the cells. Thirdly, during starvation or in uncontrolled diabetes
mellitus, when carbohydrates are either unavailable or not properly utilized, cellular
proteins, especially those from muscle tissue, will be utilized as fuel for the body.
Methionine, as an important dietary essential AA, is metabolized to succinyl-CoA
according to the pathway described in Figure 1.5, and then succinyl-CoA will enter into
the tricarboxylic acid cycle to produce energy (Wu, 2013; Liao et al., 2015).
1.6

Physiological Functions of Methionine
Like any other proteinogenic AAs, the major physiological function of Met in

animal body is to serve as one of the 20 types of building blocks for biosynthesis of body
proteins and peptides, which are indispensable organic compounds participating in
virtually all biochemical reactions and physiological activities (including structural
support). Methionine is also a precursor of many bioactive compounds including GSH,
sarcosine, taurine, choline, betaine, succinyl-CoA, homocysteine, Cys, creatine, carnitine,
and SAM (Corzo et al., 2007; Nukreaw et al., 2011; Zhai et al., 2012; Wu, 2013; Wen et
al., 2014). In addition, Met performs several other physiological functions via regulating
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the metabolic pathways related to the growth, development, immunity, and reproduction
of animals and, therefore, Met can be classified as a functional AA (Wu, 2010;
Jankowski et al., 2016). These functions include protein translation initiation (Pain, 1986;
Drabkin and RajBhandary, 1998; Pestova and Hellen, 2001; Goto et al., 2008), methyl
donation (Fontecave et al., 2004; Roje, 2006; Yue et al., 2009; Johnson, 2013; De
Berardis et al., 2016), sulfur provision (Moore et al., 2004; Bunchasak, 2009),
endogenous anti-oxidation (Luo and Levine, 2008), and immune system protection
(Tsiagbe et al., 1987; Swain and Johri, 2000; Grimble, 2006).
1.6.1

Protein Translation Initiation
Protein synthesis is universally initiated with Met. Found in all living organisms

are two species of Met tRNAs: the initiator (tRNAi), a tRNA that specifically binds the
universal start codon (AUG) on mRNA, is used for initiation of protein synthesis,
whereas the elongator (tRNAe) is used to insert Met internally during translation
(Drabkni and RajBhandary, 1998). Translation of eukaryotic mRNA is initiated by a
unique aminoacyl-tRNA, and Met-tRNAi is formed from L-Met and tRNAi by
aminoacyl-tRNA synthetase (Wu, 2013). In eukaryotic cells, the 80S ribosome is formed
from 60S and 40S subunits before the polypeptide synthesis is initiated, and Met-tRNAi
participates in this process (Wu, 2013). The start AUG codon on mRNA signals the
interaction between the ribosome and the mRNA, and further recognizes the tRNA that
contains the anticodon (Wu, 2013).
Active translation occurs on the functional 80S ribosome complex where the
ribosome reads mRNA in the 5’ to 3’ direction. The translationally active 80S ribosome
contains three RNA binding sites, designated as A, P, and E (Figure 1.6). The aminoacyl
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site (A site; a.k.a. acceptor site) binds an aminoacyl-tRNA; the peptide site (P site) binds
the nascent polypeptide chain linked to the last aminoacyl-tRNA (i.e., binding a peptidyltRNA, a tRNA bound to the peptide being synthesized); and the exit site (E site), which
allows for the release of deacylated tRNA after peptide bond formation. The initiator
tRNA occupies the ribosomal P site and is directly involved in the selection of the
translation start site on the ribosome as it scans in a 5’-3’ direction on the 5’ UTR (Cigan
et al., 1988; Pestova et al., 1998). After the translation initiation is completed, the A site
of the ribosome is free, whereas the initiator tRNAiMet occupies the P site (Kapp and
Lorsch, 2004). During this process, each tRNA that carries a corresponding AA moves
through the 80S ribosome from the A site to the P site and then exit via the E site.
Elongation factors (EF) are crucial for addition of an AA to the polypeptide and for
elongation of that peptide. Both eEF1A and eEF2 factors are remarkably conserved
throughout evolution, and protein synthesis occurs at a high speed with accuracy.
Eukaryotic and prokaryotic ribosomes can incorporate 6 and 18 AAs per second,
respectively (Wu, 2013). The AUG codons (for Met) at internal positions within an open
reading frame are not recognized by tRNAiMet and are instead decoded by the elongator
Met tRNA, tRNAeMet (Kapp and Lorsch, 2004; Wu, 2013).
After multiple cycles of elongation to polymerize multiple AAs into a protein
molecule, the completion of polypeptide chain elongation is recognized in the A site by
the terminating signal known as the nonsense or terminating codon (e.g., UGA, UAG, or
UAA) on the mRNA (Wu, 2013). Most polypeptides of proteins have no biological
activities when released from the ribosome. In eukaryotes, the polypeptides must undergo
appropriate modifications in the cytoplasm and/or on the rough endoplasmic reticulum to
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become mature proteins. These posttranslational modifications include: (1) proteolytic
cleavage, including removal of the initiating AA (e.g., Met) and the C- and N-terminal
residues (signal peptide by signal peptidase), and limited proteolysis of proproteins or
propeptides (inactive proteins or peptides); and (2) covalent modifications of AA residues
in peptides or proteins (Wu, 2013; Liao et al., 2015).
1.6.2

Methyl Donation
A key aspect of Met’s metabolic function is to produce SAM, which is

biosynthesized during the reaction of Met with ATP, catalyzed by SAM synthase or Met
adenosyltransferase (Markham et al., 1980). As an essential methyl donor that appears in
all living organisms for most of the biological methylation reactions, SAM is the second
most widely used enzyme substrate after ATP (Cantoni, 1975; Chiang et al. 1996), and
the methylation can affect diverse physiological processes from fetal development to
brain function (Fontecave et al., 2004). The key to SAM’s function as a methyl donor lies
in the sulfonium ion and in the electrophilic nature of the carbon atom that is adjacent to
the sulfur atom particularly. The positively charged sulfonium facilitates the transfer of
the methyl group to a nucleophilic acceptor to produce SAH and the methylated acceptor,
which are catalyzed by methyltransferases. An important property of the all known
methyltransferases is that they can be inhibited by their product, SAH. About 60 different
methyltransferases have been already known but the actual number of methyltransferases
is likely to be much higher (Clarke and Banfield, 2001).
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1.6.3

Anti-Oxidative Function
Various reactive oxygen and nitrogen species are normally produced during

aerobic cellular metabolism and can accumulate under stress conditions (Boschi-Muller
et al., 2008). The reactive oxygen species (ROS), such as superoxide anion (O2-) and
hydrogen peroxide (H2O2), are significant in the body that can damage cellular
macromolecules, such as proteins, lipids, and DNA, and these damages can induce
cellular oxidative stress and lead animals (including human) to increased incidences of
diseases (including the accelerated aging) (Lee and Gladyshev, 2011).
In the case of protein oxidation, all AAs are susceptible to oxidation, although
their susceptibilities vary greatly (Stadtman, 1993). Methionine is one of two common
AAs (Met and Cys) that are most susceptible to oxidation by ROS (Lavine, 1947; Vogt,
1995; Chao et al., 1997; Tien et al., 1999). Therefore, Met is considered as an
endogenous antioxidant for it can defend cells against oxidative stress (Luo and Levine,
2008) through an important antioxidant defense mechanism (Levine et al., 1999;
Jankowski et al., 2016).
In globular proteins, while most Met residues are buried inside the hydrophobic
core, some residues located on the surfaces are susceptible to oxidation to Met sulfoxide
(Brosnan et al., 2007). Methionine can even undergo oxidative deamination in the case of
metal ion-catalyzed oxidation (Lee and Gladyshev, 2011). It appears that only about 10%
of Met is converted to NH4+, RCOO−, and O2, whereas the major Met oxidation product
is Met sulfoxide (Lee and Gladyshev, 2011). A variety of oxidants react readily with Met
to form Met sulfoxide, and the surface exposed Met residues can create an extremely
high concentration of reactant, providing for efficient scavenging of oxidants. The Met
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sulfur forms a prochiral center and its oxidation results in two diastereomer products,
Met-S-sulfoxide (Met-S-SO) and Met-R-sulfoxide (Met-R-SO) (Twibell et al., 2000; Lee
and Gladyshev, 2011).
Living organisms have evolved complex antioxidant defense systems to minimize
oxidative damage to proteins and other macromolecules. Furthermore, they possess repair
systems for reversing some oxidative modifications and disposal systems for removing
modified macromolecules which are not repaired. Methionine oxidation is a reversible
covalent modification (Luo and Levine, 2008; Kim et al., 2014), so these Met sulfoxides
may be reduced back to Met by Met sulfoxide reductases, thioredoxin-dependent
enzymes that are virtually universal among aerobic organisms (Brot and Weissbach,
1983; Zhang and Weissbach, 2008). These organisms have two types of Met sulfoxide
reductases (Msr). MsrA specifically reduces Met-S-SO, but not Met-R-SO. Conversely,
MsrB reduces Met-R-SO, but not Met-S-SO. The existence of MsrA has been appreciated
for decades, while the existence of MsrB was just reported in 2001 (Grimaud et al.,
2001). Methionine may further contribute to antioxidative function when coupled with
reductases (Vogt, 1995; Dalle-Donne et al., 2002). The work of Brot and Weissbach
(1983) reported the widespread existence of Msr, capable of reducing either the free or
the protein-bound Met sulfoxide back to Met. Thus, a repair mechanism exists for dealing
with the products of the relatively facile reaction of oxidants with Met residues (Levine et
al., 1999).
The anti-oxidative ability of endogenous Met can protect many proteins from
oxidative damage. Besides the prominent role of Met oxidation and enzyme-mediated
reduction in antioxidant, increasing evidence is being compiled supporting the role of
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Met oxidation and reduction in the regulation of cell function under physiological
conditions (Hoshi and Heinemann, 2001). Cyclic oxidation and reduction of Met residues
could function as regulatory processes, including cell signaling processes (Hoshi and
Heinemann, 2001; Bigelow and Squier, 2005; Willke, 2014)
In summary, Met residues can act as endogenous antioxidant effectively (Levine
et al., 1996; Levine et al., 1999). The surface-exposed residues readily react with
oxidizing agents at physiological pH, and their effective concentration at the protein
surface is very high. Other chemical residues within the critical regions of the protein are
thus protected, and the existence of a repair mechanism means that each Met may
scavenge many oxidizing molecules.
1.6.4

Immune Function
As sulfur-containing AAs, Met and Cys have been shown to be beneficial for

animal immune system (Tsiagbe et al., 1987; Swain and Johri, 2000; Grimble, 2006).
Methionine serves as a methyl donor for several important processes, such as DNA
methylation and polyamine synthesis (Grimble, 2002), which are important to enhance
immune cell proliferation during immune challenge (Dwyer, 1979). Cysteine that can be
synthesized from Met is the rate-limiting substrate for synthesis of GSH which is a
powerful intracellular antioxidant. Besides functioning as a scavenger of free radicals and
other ROS, GSH is also involved in immune functions as it is needed for the activation of
T-lymphocytes and leukocytes and for the production of cytokines (Lu, 2009; Wu et al.,
2004).
Cysteine is needed to produce taurine, which acts as an antioxidant, as well as a
cell membrane stabilizer (Grimble, 2002), and taurine is particularly abundant in
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leucocytes (Roth, 2007). During the immune system stimulation (ISS), utilization of Cys
for the production of compounds involved in the immune response, such as GSH and
taurine, is increased (Grimble, 2002). Rakhshandeh et al. (2010) reported that the ISS by
injection of lipopolysaccharide (LPS) reduced the ratio of whole-body nitrogen- and
sulfur-balance indicating that the sulfur-containing AAs are preferentially preserved for
the production of non-protein compounds, such as GSH, to enhance immune status. This
implies that the need for Met and Cys also increases during the immune challenge
situation. Indeed, Rakhshandeh et al. (2014) reported that the ISS reduced the whole body
protein deposition but increased maintenance requirement for Met + Cys. They estimated
that an unchallenged pig needs 1.63 g standardized ileal digestible (SID) Met + Cys
intake, while an immune challenged pig needs 1.87 g SID Met + Cys intake (15%
increase) to achieve the same body protein deposition of 50 g/d.
The concentration and fractional synthesis rate of plasma albumin decreased when
immune challenged pigs were fed a low Met + Cys diet compared with the pigs fed an
adequate Met + Cys diet (Litvak et al., 2013a). In a nitrogen balance study with growing
pigs, Litvak et al. (2013b) showed that the ISS from LPS injection reduced protein
deposition rate but the optimal dietary Met to Met + Cys ratio for maximum body protein
deposition increased from 57% to 59%. Similarly, the dietary SID Met + Cys : Lys ratio
to maximize body protein deposition increases from 55% to 75% when growing pigs are
immune challenged with LPS (Kim et al., 2012). Capozzalo et al. (2017) also reported
that the ADG, ADFI, and G: F ratio for 8 to 20 kg pigs infected with E. coli and fed
antibiotic-free diets were optimized at the SID Met + Cys: Lys ratios of 0.71, 0.73, and
0.68, respectively. These results suggested that the requirements of Met + Cys (including
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the Met requirement for converting to Cys) are increased during immune challenge.
Additional dietary intake of Met + Cys can also reduce the adverse effects of ISS on
whole body protein deposition in growing pigs, and probably accelerates the recovery
from the reduced protein deposition (Wu, 2013; Litvak et al., 2011).
1.6.5

Methionine Deficiency and Methionine Toxicity
Conde-Aguilera et al. (2016) reported that the pigs fed a Met-deficient diet

(0.23% Met) had a lower body weight gain and a higher lipid deposition than the pigs fed
a basal diet (0.48% Met). In addition, the increased triglyceride content in subcutaneous
adipose tissue and unchanged plasma triglyceride content were observed in pigs fed a
Met restricted diet (0.27% Met) (Castellano et al., 2015). Castellano et al. (2015) also
showed that a rapidly growing animals (such as young pigs) could differently adapt tissue
metabolisms when facing a dietary Met deficiency. In muscle, the responses primarily
concerned malic enzyme, the main NADPH supplier regulating intramuscular fat content
in pigs. Some complex and coordinate responses of antioxidant systems were also
observed in different tissues when growing pigs faced an insufficient Met supply.
Considering the differences in growth rate, AA requirements, and regulatory mechanisms
in energy metabolism among mammalian species, the reported findings from pigs can be
of useful knowledge for interspecies comparison in the situation of dietary Met
deficiency.
Supplementation of Met much more above animal physiological requirement,
however, can cause various toxic changes including the suppression of feed intake and
body growth (Edmonds and Baker, 1987). Since the Met toxicity can be alleviated by
dietary supplementation with glycine through enhancement of Met metabolism via the
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transsulfuration pathway, it appears that the limited capacity of transsulfuration pathway,
rather than the metabolism via the transamination pathway, is primarily responsible for
the adverse effects of Met, at least on the growth and feed intake depression which
probably results from the higher Met levels in plasma and tissues (Sugiyama and
Muramatsu, 1987). Methionine toxicity is more pronounced than the toxicity of other
AAs because the optimal levels of Met intake are narrower than that of other AA intake
(Matsuzaki et al., 2005). The characteristic features of excessive Met intake also differ
from those of others. Excessive intake of Met promotes methemoglobin accumulation
and Heinz-body formation in erythrocytes, and causes morphological changes in
erythrocytic membrane, which leads to hemolytic anemia and to tissue morphological
changes, such as darkening and enlargement of spleen, erythrocyte accumulation in
sinusoids, and hemosiderin deposition in spleen (Toue et al., 2006).
1.7

Conclusions
Methionine plays very important roles in protein synthesis, methyl donation, anti-

oxidation, and immune defense of animals. However, among different forms of
commercial Met products, there are some differences existing during their absorption and
metabolic utilization. More research is still needed to explore if the differences among
these product forms affect Met nutritional value in pigs and other monogastric animals
differently. Understanding Met metabolism and functions in pigs can also be of useful
knowledge for interspecies comparison, considering that there are similarities in the
growth rate, AA requirements, and regulatory mechanisms in nutrient metabolism among
monogastric species.
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Transporters of methionine in animal cells*

Table 1.1

Gene
Protein
System
Na -Independent Systems
SLC7A5
LAT1/4F2hc
L
+
SLC7A6
y LAT2/4F2hc
y+ L
+
SLC7A7
y LAT1/4F2hc
y+ L
SLC7A8
LAT2/4F2hc
L
SLC43A1
LAT3
L
SLC43A2
LAT4
L
Na+-Dependent Systems
SLC6A14
ATB0,+
B0,+
SLC6A15
B0AT2
B0
0
SLC6A17
NTT4/B AT3
B0
SLC6A19
B0AT1
NBB** (B0)
SLC6A20
IMINO
IMINO
SLC38A1
SNAT1 (SAT1)
A
SLC38A2
SNAT2 (SAT2)
A
SLC38A4
SNAT4 (SAT3)
A
Not assigned
Not known
Phe
* Adopted from Wu, G. 2013. Amino acids: biochemistry and nutrition. CRC Press, Boca
Raton. FL, USA.
** NBB, neutral brush border.
+
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Figure 1.1

The chemical structure difference between L-methionine and Dmethionine.
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Figure 1.2

A schematic view of the conversion of D-HMTBA, L-HMTBA, and Dmethionine to L-methionine.

All the isomers have the same general conversion pathway with an initial oxidation step
to keto-methionine followed by transamination to L-methionine. The major difference
among the sources is that D-methionine yields ammonia as a byproduct of oxidation
while HMTBA yields water (Dibner, 2003)
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Figure 1.3

A schematic view of L-methionine absorption from small intestinal lumen
to portal bloodstream.

L-methionine can be transported inside enterocytes through the Na+ -dependent B0 system
and A system and Na+-independent L system and y+L system present in the brush border
membranes (BBM). Oligopeptides (containing, for instance, L-methionine) have to be
degraded to dipeptides and tripeptides by BBM before being transported into enterocytes
through PepT1 transporters. Then, L-methionine is released from di- and tripeptides by
cytosolic peptides. The intracellular L-methionine not used for metabolism will be
released into the portal bloodstream through basolateral membranes using various
transport systems (Soriano-Garcia et al., 1998; Matthews, 2000).
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Figure 1.4

Structure of methionine (also known as α-amino-γ-methylthiobutyric acid).

As a γ-methylthiobutyric acid with α-amino group and a side chain that contains a sulfur
atom, methionine is classified in the group of neutral amino acids.
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Figure 1.5

Major pathways of methionine metabolism, including transmethylation and
remethylation (methionine cycle), and transsulfuration (Finkelstein, 1990;
Brosnan and Brosnan, 2006; Wu, 2013).

As a γ-methylthiobutyric acid with α-amino group and a side chain that contains a sulfur
atom, methionine is classified in the group of neutral amino acids. 1. methionine
adenosyltransferase; 2. Betaine : homocysteine methyltransferase; 3. methionine
syhthase; 4. methyl transferase; 5. glycine N-methyltransferase; 6. Sadenosylhomocysteine hydrolase; 7. cystathionine ß-synthase; 8. cystathionine g-lyase (a
pyridoxal phosphate-dependent enzyme); 9. a-ketobutyrate dehydrogenase; 10. a series
of enzymes including propionyl-CoA carboxylase, methylmalonyl-CoA racemase, and
methylmalonyl-CoA mutase (a vitamin B12-dependent enzyme); 11. serine
hydroxymethyltransferase; 12. methylenetetrahydrofolate reductase.
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Figure 1.6

The initiation of protein synthesis (Watson et al., 2014).

The translationally active 80S ribosome contains three RNA binding sites, designated as
A, P, and E. The aminoacyl site (A site; a.k.a. acceptor site) binds an aminoacyl-tRNA;
the peptide site (P site) binds the nascent polypeptide chain linked to the last aminoacyltRNA (namely, binding a peptidyl-tRNA, a tRNA bound to the peptide being
synthesized); and the exit site (E site), which allows for the release of deacylated tRNA
after peptide bond formation
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EFFECTS OF DIETARY SUPPLEMENTATION OF L-METHIONINE VS DLMETHIONINE ON PERFORMANCE, PLASMA CONCENTRATIONS OF FREE
AMINO ACIDS AND METABOLITES, AND MYOGENESIS GENE EXPRESSION
IN YOUNG GROWING PIGS
2.1

Introduction
Pig is one of the most economical livestock species that provides pork, an

excellent source of dietary protein for human consumption (Wu et al., 2014; Hou et al.,
2015; Liao et al., 2015). The primary tissue component of pork products is skeletal
muscle, and in modern swine industry, the efficiency of pork production is measured by
the efficiency of lean gain (i.e., the muscle gain) rather than the whole body weight gain
(Liao et al., 2015). Thus, the knowledge concerning the growth and development of
skeletal muscle in pigs is crucial from both the economic and the production standpoint.
As the most abundant tissue in pig body, skeletal muscle in general accounts for
20 to 50% of the total body mass, serving as the largest pool of body proteins and
exhibiting major metabolic activities by contributing up to 40% of the resting metabolic
rate (Bell et al., 2016). As the major chemical component in muscle, proteins are
synthesized from AAs, which originate from dietary protein sources including
supplemented crystalline AAs (O'Connor et al., 2003; Li et al., 2016). There are about 20
AAs in nature serving as building blocks for protein synthesis and, hence, called
proteinogenic AAs. Nevertheless, not all these AAs are indispensable dietary components
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because the pig can synthesize about 10 of them de novo. Consequently, the essential
AAs are defined as those that need to be supplied exogenously through the diet because
pigs cannot synthesize them or cannot synthesize enough to meet their metabolic needs
(NRC, 2012).
Met, typically the third limiting AA in corn-soybean based diets, plays very
important roles in exerting many metabolic and physiological functions for pigs,
including functioning as a major methyl donor, as an important source of sulfur, as an
endogenous antioxidant, and as precursors of many bioactive compounds (Zhai et al.,
2012; Shen et al., 2014). Previous research reported that dietary supplementation of Met
can increase nitrogen (N) retention and muscle protein accretion in pigs via increasing
protein synthesis and decreasing protein degradation and, thus, improving growth
performance (Chung and Baker, 1992a; Zimmermann et al., 2005; Kim et al., 2006; Wen
et al., 2014; Kong et al., 2016a,b).
Dietary Met supplementation has been practiced for many years in swine industry.
Feed-grade crystalline DL-Met has been the standard form of commercial Met products,
which consists of 50% D-Met and 50% L-Met. Recently, another form of feed grade Met,
L-Met, is available on the market. The L-Met products are produced from either chemical
synthesis or fermentation of plant-based raw materials (Willke, 2014). As a new form of
Met product, several research projects have been conducted to investigate its nutritional
efficacy (Shen et al., 2014; Tian et al., 2016; Kong et al., 2016a, b). However, some
distinguished features of L-Met are still unknown, especially the mechanism by which LMet affects pig muscle growth. This study was conducted to investigate the effects of LMet vs. DL-Met on growth performance, plasma concentrations of 22 free AAs and 6
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representative metabolites, as well as the expression of 8 myogenesis genes in growing
pigs.
2.2
2.2.1

Materials And Methods
Animal Feeding Trial
The experimental protocols involving caring, handling, and treatment of pigs were

approved by the Mississippi State University Institutional Animal Care and Use
Committee. Briefly, 20 crossbred (Large White × Landrace × Duroc) young growing
barrows were purchased from a local commercial farm and transferred to an
environmentally controlled swine barn at the Leveck Animal Research Center of
Mississippi State University. After arrival, pigs were assigned to 5 pens and fed a
commercial nursery diet until their BW reached 21.2 ± 2.7 kg, during which period pigs
were allowed ad libitum access to feed and water. Pigs were then randomly assigned to
20 individual feeding pens, and further allotted to 2 dietary treatments according to a
completely randomized experimental design with pigs serving as experimental units.
Based on the chemical analysis for AA content of feedstuffs (corn and soybean)
used, two corn and soybean meal based diets (Diets 1 and 2) were formulated to meet the
NRC (2012) recommended requirements for energy, crude protein, minerals, and
vitamins. For essential AAs, the requirement standards of AMINODat 5.0 (Platinum
Version, 2016. Evonik Nutrition & Care GmbH, Hanau, Germany) were followed.
Crystalline L-Met and DL-Met were supplemented to Diets 1 and 2 (both at 0.13%, asfed basis), respectively, to meet pigs' requirement for Met (Table 2.1). Supplemental DLMet (MetAMINO®) and L-Met were obtained from Evonik Nutrition & Care GmbH (a
commercial company located in Hanau-Wolfgang, Germany). To confirm the contents of
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major nutrients, representative samples of the two diets were submitted to the Essig
Animal Nutrition Laboratory at Mississippi State University for energy and proximate
analyses, and to an Evonik's laboratory in Hanau-Wolfgang, Germany for AA analysis.
The analyzed composition of selected nutrients contained in the two experimental diets
are shown in Table 2.2.
During the 4 week feeding trial, pigs were allowed ad libitum access to the
experimental diets, and fresh water. All feeders and waterers were checked at least thrice
daily (06:00 to 22:00 hr) to ensure proper function of the facilities and normal behavior
of the animal. Any refusal feed was collected on weight dates and returned to the feeders
immediately or reserved and weighed for feed intake calculation. Pigs' BW were
measured on Day 0, and Day 28, the 4 week feeding trial. Pigs' feed intake was measured
for the 4-week period. The ADG, ADFI, and G:F were then calculated accordingly.
2.2.2

Sample Collection And Analyses
At the beginning and the end of the 4 week feeding trial, blood samples were

collected via jugular venipuncture (approximately 10 mL/pig) in early morning (between
06:00 and 08:00 hr). Immediately before blood collection, the remaining feed in all
feeders were removed to avoid any re-pushed concentrations of nutrients to the blood
stream following eating, until blood collection finished. Immediately after collection, the
blood samples were kept on ice until plasma was separated within 30 minutes by
centrifugation of the samples for 16 min at 800 × g and 4°C. Plasma samples in 500-µL
aliquots were then stored at -80°C until the laboratory analyses of nutrient metabolites
and free AAs.
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After blood collection, a muscle sample (about 200 mg) was collected from the
middle portion of longissimus dorsi of each pig using our standard aseptic biopsy
protocol (Burnett et al., 2015). All muscle samples collected were snap frozen in liquid
N, and then transferred to a -80°C freezer for storage until analyses.
For determination of plasma metabolites, batch analysis was performed using the
automated ACE Alera Clinical Chemistry System (Alfa Wassermann, West Caldwell,
NJ) with six respective ACE reagents (Alfa Wassermann) for glucose, total protein,
albumin, urea N, total cholesterol, and total triglycerides. Determination of these
metabolites involved enzymatic reactions with appropriate enzymes, followed by
bichromatic measurements of respective reaction products at different wavelengths to
determine the concentrations. Briefly, glucose assay was conducted using the hexokinase
method (Todd et al., 1979). Urea N concentration was determined using the UreaseGLDH method (Tietz et al., 1995). The cholesterol assay was conducted using a
hydrolysis method involving cholesterol esterase, cholesterol oxidase and peroxidase
(Artiss et al., 1997). The triglyceride assay was also conducted with an enzymatic method
involving lipase, glycerol kinase, glycerol phosphate oxidase and peroxidase (Kalia and
Pundir, 2004). The assay of albumin concentration involved specific binding of
bromocresol green to albumin (Tietz et al., 1995). Likewise, the assay of total protein
involved a reaction of cupric ions with peptide bonds under alkaline conditions (Tietz et
al., 1995).
The concentrations of plasma free AAs were determined using high-performance
liquid chromatography (HPLC) methods (Liao et al., 2005; Wu and Meininger, 2008; Dai
et al. 2014). Briefly, after a pre-column derivatization of plasma AAs with o37

phthaldialdehyde, the samples were separated on a Supelco 3-µm reversed-phase C18
column (4.6 × 150 mm, i.d.) guarded by a Supelco 40-µm reversed-phase C18 column
(4.6 × 50 mm, i.d.). The HPLC mobile phase consisted of solvent A (0.1 M sodium
acetate/0.5% tetrahydrofuran/9% methanol; pH 7.2) and solvent B (methanol), with a
combined total flow rate of 1.1 mL/min. A gradient program with a total running time of
49 min was developed for satisfactory separation of AAs.
2.2.3

Gene Expression Analyses
Total RNA was extracted from approximately 50 mg of muscle sample per animal

using TRIzol Reagent (Invitrogen Corporation, Carlsbad, CA) according to the
manufacturer's instructions. Briefly, frozen tissue was homogenized in a 15-mL
polypropylene centrifuge tube using a Polytron mixer (0.5 mL TRIzol per 50 mg tissue),
and the homogenate transferred to a 1.5-mL micro-centrifuge tube. Chloroform (400
µL/tube) was used to separate RNA from DNA and proteins, and then the total RNA was
precipitated with isopropyl alcohol (at 1:1 ratio) and washed with 750 µL of 75% ethanol.
The resulted RNA was air-dried, dissolved in 60 µL RNase-free water, and stored at 80°C freezer. The purity and concentration of the RNA samples were measured using
ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE).
First-strand cDNA were reverse-transcribed from 1 µg of total RNA by using
QuantiTect Reverse Transcription Kit (Qiagen, Valencia, CA). The semi-quantitative
PCR analysis was performed using the Rotor-Gene Q System and the Rotor-Gene SYBR
Green PCR Kit (Qiagen), followed by melting curve analysis to verify the specificity and
identity of the PCR products. The thermal cycling parameters were 95°C for 5 min,
followed by 40 cycles of 95°C for 5 s and 60°C for 10 s. Primers for the selected genes
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were designed by using PrimerQuest Tool (Integrated DNA Technologies, Coralville,
IA). The sequences of the designed primers and the relevant information associated with
the PCR primers are shown in Table 2.3. Also shown in Table 2.3 is the endogenous
control gene, Hprft1 (hypoxanthine phosphoribosyl transferase 1), used for normalization
of any variation during the sample preparation (Nygard et al., 2007).
The comparative ΔΔCT method was used for mRNA quantity calculation. Briefly,
the raw quantity of a given gene was normalized against the raw quantity of Hprft1
reference gene of a given sample obtained from the Rotor-Gene Q System, and then the
normalized level of the given gene of each sample was expressed as a quantity relative to
the mean of the normalized quantities of the given gene of the Diet 2 samples.
2.2.4

Statistical Analysis
All data were subjected to statistical analysis with Student T-test by using the

SAS software (version 9.4; SAS Institute Inc., Cary, NC). A P-value less than 0.05 was
considered as a significant difference between treatment means, and a P-value between
0.05 and 0.10 as a tendency. Each value of the measurements is presented as mean ± SD.
2.3

Results
As shown in Table 2.2, the analyzed contents of nutrients, especially, the CP and

AAs, in the two experimental diets were similar and close to the calculated values (Table
2.1). As to the growth performance, the initial BW were not different (P = 0.94) between
the two treatment groups of pigs (Table 2.4). At the end of the feeding trial, the final BW
of pigs fed Diet 1 and Diet 2 were not different (P = 0.94). The overall ADG (P = 0.87),
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ADFI (P = 0.69), and G:F (P = 0.56) between the two dietary treatments were not
different.
To understand the possible metabolic mechanism responsible for growth
performance, several selected plasma metabolites were examined. As shown in Table 2.5,
before the feeding trial, there was no difference in the plasma concentrations of urea N,
total protein, albumin, glucose, total cholesterol, and triglycerides between the pigs fed
Diets 1 and 2 (P = 0.17 to 1.00). After feeding the experimental diets for 4 weeks, there
were no differences in the plasma concentrations of urea N, albumin, glucose, total
cholesterol, and triglycerides (P = 0.38 to 0.93), although the plasma total protein
concentration of the pigs fed Diet 2 tended to be higher than that of the pigs fed Diet 1 (P
= 0.10). The overall results showed pigs fed the L-Met supplemented diets showed
similar response on the plasma concentrations of these 6 selected metabolites when
compared with the pigs fed the DL-Met supplemented diets.
Methionine is one of the essential AAs for protein synthesis. As indications of
protein synthesis affected by different forms of Met sources, plasma concentration of 22
free AAs were analyzed in this study. At the beginning of the feeding trial, there were no
differences (P = 0.12 to 0.98) in the plasma concentrations of all these AAs between the
two groups of pigs (Table 2.6). After feeding the pigs for 4-weeks, the plasma
concentrations of all these AAs were not different between the two groups of pigs (Table
2.7; P = 0.20 to 0.99), which indicated that the AA metabolism and protein synthesis
were not altered by the Met forms.
Eight myogenesis related genes, which are myogenic differentiation 1 (MyoD1),
myogenic factor 5 (Myf5), myogenin (MyoG), and muscle regulatory factor 4 (Mrf4,
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a.k.a. Myf6), myocyte enhancer factors 2A (Mef2A), 2B (Mef2B), 2C (Mef2C), and 2D
transcript variant X1 (Mef2D) were selected to be tested for the levels of their mRNA
expression in longissimus dorsi muscle of pigs. Before the feeding trial, the mRNA
expression levels of these 8 genes were similar (P = 0.14 to 1.0) between pigs fed Diets 1
and 2 (Table 2.8). After the 4-week feeding trial, there were no differences (P = 0.18 to
0.94) between these two groups of pigs in the expression levels of these 8 genes (Table
2.8). These results indicated that the dietary supplementation of L-Met vs DL-Met do not
affect the expression of myogenesis related genes differently.
2.4
2.4.1

Discussion
Growth Performance
As previously reported, L-Met can be directly used by animals for metabolism

and synthesis of proteins (Dibner and Ivey, 1992; Stoll et al., 1998; Martín-Venegas et
al., 2006; Shen et al., 2014; Willke, 2014; Tian et al., 2016; Kong et al., 2016a). Dmethionine, however, must be converted to L-Met via a biochemical pathway (Figure
1.2) to become bioavailable for metabolic processes including muscle growth in pigs
(Baker, 2006). Metabolic utilization of exogenous D-Met depends on whether it can be
efficiently transformed to L-Met. Thus, for a DL-Met product, composed of 50% D-Met
and 50% L-Met, the efficacy of its utilization relies on the efficiency of its metabolic
conversion to L-Met. Previous studies demonstrated that all D-Met can be converted to
L-Met by pigs (Wretlind and Rose, 1950; Cho and Stegink, 1979; Sugiyama and
Muramatsu, 1987; Hasegawa et al., 2005; Kong et al., 2016b). Indeed, the capacity of the
rate-limiting enzyme, i.e., D-amino acid oxidase (D-AAOX), to convert D-Met to L-Met
is not limiting in pigs (Fang et al., 2010) and poultry (Brachet and Puigserver, 1992) due
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to the existence of substantial D-AAOX activity in different tissues including liver and
kidney (major sites conversion), and also gastrointestinal tract (stomach, duodenum,
jejunum and ileum).
Although a tendency of increasing ADG in weaned pigs by dietary L-Met (vs.
DL-Met) supplementation was reported (Reifsnyder et al., 1984; Shen et al., 2014),
several other studies reported that the pigs fed with L-Met supplemented diets had no
difference in growth performance when compared with the pigs fed with DL-Met
supplemented diets (Chung and Baker, 1992b; Chen et al., 2013; van Milgen et al., 2013;
Kong et al., 2016a,b). Htoo and Morales (2016) also found that the growth performance
of weaned pigs fed diets supplemented with the same inclusion levels of DL-Met and LMet were not different and, thus estimated a 100% relative bioavailability using a sloperatio regression. Using a N-balance method, Tian et al. (2016) showed that dietary
supplementation with L-Met or DL-Met (at the same inclusion level) to a Met-deficient
diet improved N retention and decreased fecal N excretion, but there were no differences
between the L-Met and DL-Met supplemented diets in terms of N retention or fecal N
excretion. These results indicated that DL-Met and L-Met as Met sources for pigs are
equally bioavailable, which is consistent with the results of this present study.
2.4.2

Plasma Metabolites and Free Amino Acids
Several plasma parameters, such as plasma urea N, total protein, albumin, total

cholesterol, triglycerides, and glucose, are general indicative of nutritional status of
animals (Wen et al., 2014). As an indicator of AA utilization by pigs, plasma
concentration of urea N can be used as a sensitive parameter to identify dietary AA
imbalance (Coma et al., 1995; Chen et al., 1999a,b). Plasma albumin accounts for 60% of
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the total plasma proteins and is a major contributor for maintaining plasma osmotic
pressure for assisting with transporting lipids and steroid hormones (Matejtschuk et al.,
2000; Regmi et al., 2017). The level of plasma albumin is also a good indicator of the
effectiveness of dietary protein utilization, as well as of the protein synthesis capacity of
the liver (Lowrey et al., 1962; Mahdavi et al., 2012; Regmi et al., 2017). The plasma
concentration of glucose, triglycerides and cholesterol reflect the metabolic status of
energy and lipids.
Shen et al. (2014) reported that the pigs fed with L-Met supplemented diets had
lower concentrations of plasma urea N than the pigs fed with DL-Met supplemented diets
on day 10 but not different on day 20. However, Tian et al. (2016) reported that pigs fed
with L-Met supplemented diets had similar plasma concentrations of albumin, total
protein, and plasma urea N when compared with pigs fed with DL-Met supplemented
diets, which is consistent with the results observed in this present study.
In this study, pigs fed with the L-Met supplemented diet had similar
concentrations of Met and all other AAs, as well as taurine (an end product of Met
metabolism), compared with the pigs fed with the DL-Met supplemented diet. These
results agree with Tian et al. (2016), who reported that L-Met supplementation did not
lead to any difference in plasma AA concentrations of pigs when compared with DL-Met
supplementation. These results suggest that the same amount of L-Met and DL-Met may
provide similar amount of final L-Met for the nutritional utilization by pigs. Altogether,
the results obtained from this study indicate that the effects of L-Met and DL-Met on AA,
lipid, and energy metabolism are the same or similar.
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2.4.3

Myogenic Gene Expression
Myogenesis, the process of muscle growth, is regulated by a broad spectrum of

cell signaling molecules (Bentzinger et al., 2012). Among the hierarchical interactions
between those molecules, the families of myogenic regulatory factors (MRFs) and
myocyte enhancer factor 2 (MEF2) for the transcription factor-mediated regulation, are
key regulators of muscle growth and development, and have been a focus of many
previous studies in humans and animals (Townley-Tilson et al., 2010; Wen et al., 2014).
However, until now little is known about the effects of Met on the expressions of these
factors in swine.
It is known that while the MEF2 family comprise Mef2A, Mef2B, Mef2C, and
Mef2D, the MRF family comprise MyoD1, Myf5, MyoG, and Mrf4. It is also known that
the MRF family are highly conserved and are collectively expressed in the skeletal
muscle of humans (Bentzinger et al., 2012). Assisted by the MEF2 family of transcription
factors (together with other general and muscle-specific factors), MRFs coordinate the
activities of a host of co-activators and co-repressors, resulting in a tight control of gene
expression during myogenesis (Black and Olson, 1998; Berkes and Tapscott, 2005).
In this present study, there were no differences between the pigs fed with the LMet supplemented diet and the pigs fed with the DL-Met supplemented diet in the mRNA
expression levels of all 8 myogenesis related genes in longissimus dorsi muscle before
and after the 4-week feeding trial. The similar expression levels of these genes in the pigs
fed two different diets indicate no difference between L-Met and DL-Met in terms of
their effects on the muscle growth and development of growing pigs. These gene
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expression data together with the performance data suggest that D-Met can be efficiently
converted into L-Met to provide enough biological Met for pig myogenesis.
2.5

Conclusions
The results of this study showed that the same supplementation level of dietary L-

Met and DL-Met led to similar growth performance of young growing pigs. The pigs fed
the L-Met supplemented diet had similar nutritional status as the pigs fed the DL-Met
supplemented diet, which was reflected by the results of the concentrations of plasma
metabolites and free AAs. The expression of myogenesis genes by the pigs were also not
affected by the two Met sources. With the same nutritional bioefficacy between L-Met
and DL-Met, the selection between the two for feeding pigs can be exchangeable
assuming the commercial prices for the two sources of Met are the same.
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Table 2.1

Composition of the experimental diets fed to the growing pigs (as-fed
basis)
Dietary treatment6
Diet 1
Diet 2

Item
Ingredient, %
Corn
Soybean meal
Poultry fat
L-Lysine HCl, 78.8%1
Methionine, 99%2
L-Threonine, 98.5%1
L-Tryptophan, 98%1
L-Isoleucine, 96%
L-Valine, 96.5%1
L-Cysteine HCl, 99.7%1
Limestone
Dicalcium phosphate
Salt
Mineral premix3
Vitamin premix3
Total
Major nutrients, calculated
Dry matter, %
Net energy, kcal/kg
Crude fat
Crude fiber
Ash
SID crude protein, %4
SID lysine, %
SID methionine, %
SID methionine + cysteine, %
SID threonine, %
SID tryptophan, %
SID valine, %
SID isoleucine, %
Total calcium, %
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74.88
20.00
1.27
0.58
0.13
0.24
0.07
0.10
0.18
0.09
0.81
1.30
0.18
0.10
0.07
100.00

74.88
20.00
1.27
0.58
0.13
0.24
0.07
0.10
0.18
0.09
0.81
1.30
0.18
0.10
0.07
100.00

87.86
2,440
4.17
2.30
2.14
14.14
1.08
0.37
0.67
0.70
0.22
0.80
0.66
0.66

87.86
2,440
4.17
2.30
2.14
14.14
1.08
0.37
0.67
0.70
0.22
0.80
0.66
0.66

STTD phosphorus, %5
0.37
0.37
Crude fiber, %
2.30
2.30
Ash, %
2.14
2.14
1
L-lysine HCl (containing 78.8% L-lysine) and L-threonine were purchased from Archer
Daniels Midland Co. (Quincy, IL). L-tryptophan and L-valine were donated from
Ajinomoto Heartland, Inc. (Chicago, IL). L-Cysteine HCl (containing 76.9% L-cysteine)
was purchased from Wuhan Grand Hoyo Co., Ltd. (Wuhan, Hubei, China).
2
L-methionine and DL-methionine (MetAMINO®) were obtained from Evonik Nutrition
& Care GmbH (Hanau, Germany) and used in Diets 1 and 2, respectively.
3
Mineral premix (No. NB-8534) and vitamin premix (No. NB-6508A) were donated from
Nutra Blend, LLC. (Neosho, MO). The calculated mineral and vitamin contents in both
diets were (per kg of diet):Na, 1.0 g; Cl, 2.8 g; K, 6.1 g; Mg, 1.4 g; S, 1.5 g; Cu, 16.7 mg;
Fe, 172.0 mg; I, 0.20 mg; Mn, 37.9 mg; Zn, 132.1 mg, Se, 0.28 mg; vitamin A, 3,081 IU;
vitamin D3, 385 IU; vitamin E, 29.5 IU; vitamin K, 1.23 mg; vitamin B1, 2.29 mg;
vitamin B2, 3.65 mg; niacin, 36.2 mg; vitamin B5, 13.3 mg; vitamin B6, 5.02 mg; biotin,
0.10 mg; folacin, 0.39 mg; vitamin B12, 10.8 µg, and choline, 1.39 mg.
4
SID = standardized ileal digestible.
5
STTD = standardized total tract digestible.
6
Diet 1 = a L-methionine supplemented diet; Diet 2 = a DL-methionine supplemented
diet.
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Table 2.2

The analyzed nutrient composition (%, or as indicated) of the two
experimental diets fed to the growing pigs (as-fed basis)
Dietary treatment1
Diet 1
Diet 2

Nutrient and energy2

Proximate analysis
Dry matter
88.8
88.7
Gross energy (kcal/kg)
3,969
3,944
Crude protein
16.28
16.72
Crude fat
3.28
2.94
Crude fiber
2.03
1.87
Ash
4.13
4.44
Dietary total amino acid
Lysine
1.23
1.28
3
Methionine
0.41
0.41
Cysteine
0.33
0.33
Methionine + cysteine
0.74
0.75
Threonine
0.84
0.82
Tryptophan
0.26
0.25
Arginine
1.02
1.01
Histidine
0.43
0.43
Leucine
1.43
1.41
Isoleucine
0.74
0.74
Valine
0.94
0.95
Phenylalanine
0.77
0.76
Proline
1.00
1.01
Aspartic acid
1.56
1.52
Glutamic acid
2.84
2.79
Serine
0.80
0.78
Alanine
0.85
0.84
Glycine
0.66
0.66
Dietary free amino acid
Lysine
0.43
0.48
Methionine
0.14
0.16
Threonine
0.25
0.25
Valine
0.20
0.22
Isoleucine
0.10
0.10
1
Diet 1 = a L-methionine supplemented diet; Diet 2 = a DL-methionine supplemented
diet.
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2

Proximate and energy analyses were conducted at the Essig Animal Nutrition
Laboratory, Mississippi State University (Starkville, MS). Amino acid analyss were
conducted at the analytical laboratory of Evonik Nutrition & Care GmbH (HanauWolfgang, Germany).
3
Methionine levels in this study meet the NRC requirement for the pigs used in this study
(NRC, 2012).
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2

1

HPRFT1

NM_001032376

XM_003125698

NM_001044540

XM_003362215

NM_001097421

NM_001244672

NM_001012406

NM_001278775

NM_001002824

RefSeq ID1

GCTATGCCCTTGACTACAATGA
TTGAACTCTCCTCTTAGGCTTTG

AAGAGGAAGTTCGGGCTGAT
CTCCGTGTACTTGAGCAGCA

CCAGGCAGCAAGAATACGAT
TTGTTGAAATGGCTGATGGA

GCTCTGCGACTGTGAGATTG
GTCTCGAGGATGTCGGTGTT

GGTGCTGACGGGTACAACTT
AATTCCTGCATTCGTTCCTG

ACAAAATGCAGGAGCTAGGC
CTCCTTCCTTGGCAGTCATC

AGTGCCCCTGGAAGATAAGG
GGCCTCATTCACCTTCTTGA

GACGAGTTTGAGCCACGAGT
ATTTCCTCTTGCACGCTTTG

TAGTGGTCTTGCGTTTGCAC

CCTAAAGCCCGAGGAACACT

Primer sequence2

102

147

148

150

149

150

160

148

152

Amplicon size, bp

All these RefSeq sequences are porcine (Sus scrofa) specific from NCBI (http://www.ncbi.nlm.nih.gov/refseq/rsg/).
Forward and reverse primers for each of the nine genes are presented in the 5' to 3' direction.

1

phosphoribosyl transferase

Hypoxanthine

2D, transcript variant X1

MEF2D

Myocyte enhancer factor

MEF2A

Myocyte enhancer factor 2A

MEF2C

MRF4

Myogenic Regulator factor 4

Myocyte enhancer factor 2C

MYF5

Myogenic factor 5

MEF2B

MYOG

Myogenin

Myocyte enhancer factor 2B

MYOD1

Myogenic differentiation 1

Gene symbol

Real-time PCR primers for the selected genes

Gene name

Table 2.3

Table 2.4

Growth performance of the pigs fed a L- vs DL-methionine supplemented
diet1
Dietary treatment

Item
Diet 1
Diet 2
P-value2
Initial body weight, kg
21.3 ± 2.68
21.2 ± 2.80
0.942
Final body weight, kg
48.0 ± 5.71
48.2 ± 5.35
0.942
Average daily gain, kg/day
0.95 ± 0.12
0.96 ± 0.13
0.868
Average daily feed intake, kg/day
1.71 ± 0.23
1.75 ± 0.24
0.691
Gain:feed
0.56 ± 0.02
0.55 ± 0.03
0.560
1
Diet 1 = a L-methionine supplemented diet; Diet 2 = a DL-methionine supplemented
diet. The calculated dietary standardized ileal digestible methionine contents in both
Diets 1 and 2 were 0.37% (as-fed basis). Each value is a Mean ± standard deviation (n =
10).
2
P-values were obtained from Student T-test
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Table 2.5

The concentrations of selected metabolites in the blood plasma of growing
pigs before and after the four week feeding trial 1
Dietary treatment
Diet 1
Diet 2

Metabolites
P-value2
Before the feeding trial
Urea nitrogen, mg/dL
9.00 ± 1.82
8.00 ± 1.25
0.170
Total protein, g/dL
4.54 ± 0.49
4.78 ± 0.42
0.258
Albumin, g/dL
2.34 ± 0.33
2.34 ± 0.28
1.000
Glucose, mg/dL
118.3 ± 17.86
127.0 ± 15.10
0.255
Total cholesterol, mg/dL
76.1 ± 14.62
77.9 ± 9.72
0.750
Triglycerides, mg/dL
40.3 ± 16.39
41.9 ± 12.16
0.807
After the feeding trial
Urea nitrogen, mg/dL
6.30 ± 2.63
6.40 ± 2.59
0.933
Total protein, g/dL
5.46 ± 0.32
5.70 ± 0.3
0.096
Albumin, g/dL
3.37 ± 0.17
3.46 ± 0.26
0.376
Glucose, mg/dL
114.5 ± 11.8
111.4 ± 7.68
0.496
Total cholesterol, mg/dL
74.1 ± 12.11
74.6 ± 11.45
0.926
Triglycerides, mg/dL
47.5 ± 10.69
51.3 ± 22.11
0.631
1
Diet 1 = a L-methionine supplemented diet; Diet 2 = a DL-methionine supplemented
diet. The calculated dietary standardized ileal digestible methionine contents in both
Diets 1 and 2 were 0.37% (as-fed basis).
2
P-values were obtained from Student T-test
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Table 2.6

The concentrations of free amino acids in the blood plasma of growing pigs
before being fed two experimental diet1
Dietary treatment

Amino acid, nmol/mL2
Lysine

Diet 1
61.8 ± 13.95

Diet 2
75.3 ± 30.00

P-value3
0.222

Methionine

50.7 ± 11.38

43.6 ± 15.74

0.259

Leucine

153.7 ± 40.18

126.7 ± 43.26

0.166

Histidine

107.9 ± 65.47

118.0 ± 43.17

0.689

Phenylalanine

80.3 ± 13.44

75.8 ± 18.74

0.548

Isoleucine

90.5 ± 28.60

77.6 ± 28.8

0.326

Threonine

283.7 ± 113.07

254.4 ± 119.78

0.580

Valine

153.4 ± 44.42

129.6 ± 41.15

0.230

Tryptophan

46.0 ± 14.04

45.9 ± 15.92

0.983

Arginine

164.5 ± 33.00

153.2 ± 40.06

0.502

Citrulline

79.3 ± 29.61

91.6 ± 89.11

0.684

Alanine

542.6 ± 148.68

428.3 ± 162.33

0.118

Glutamate

233.2 ± 149.57

161.1 ± 94.16

0.213

Glycine

675.4 ± 131.07

657.6 ± 295.51

0.864

Asparagine

94.4 ± 26.63

77.8 ± 30.93

0.213

Aspartate

24.2 ± 10.60

17.8 ± 7.18

0.133

β-Alanine

29.0 ± 25.61

36.7 ± 38.86

0.610

Glutamine

1082.5 ± 299.35

945.1 ± 288.42

0.310

Ornithine

134.0 ± 28.03

125.4 ± 39.91

0.575

Serine

140.5 ± 37.66

128.5 ± 49.86

0.552

Taurine

102.6 ± 48.16

86.1 ± 33.67

0.386

Tyrosine
96.4 ± 22.73
81.1 ± 18.91
0.119
1
Diet 1 = a L-methionine supplemented diet; Diet 2 = a DL-methionine supplemented
diet. The calculated dietary standardized ileal digestible methionine contents in both
Diets 1 and 2 were 0.37% (as-fed basis).
2
Each value is a Mean ± Standard deviation (n = 10).
3
P-values were obtained from Student T-test.
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Table 2.7

The concentrations of free amino acids in the blood plasma of growing pigs
after being fed two experimental diets for four weeks1
Dietary treatment

Amino acid, nmol/mL2
Lysine

Diet 1
203.9 ± 144.55

Diet 2
203.3 ± 104.14

P-value3
0.992

Methionine

52.6 ± 29.55

47.9 ± 20.30

0.684

Leucine

182.0 ± 85.5

215.1 ± 90.28

0.410

Histidine

105.6 ± 37.63

106.6 ± 54.70

0.964

67.8 ± 34.83

75.8 ± 30.70

0.591

Isoleucine

124.0 ± 77.00

141.4 ± 65.35

0.592

Threonine

264.9 ± 174.83

293.9 ± 144.97

0.691

Valine

311.5 ± 202.19

348.0 ± 182.09

0.676

77.9 ± 36.97

88.7 ± 34.05

0.505

Arginine

153.5 ± 88.82

162.3 ± 55.42

0.795

Citrulline

63.7 ± 32.94

56.4 ± 21.26

0.555

Alanine

558.7 ± 332.46

578.2 ± 287.69

0.890

Glutamate

298.6 ± 229.07

259.9 ± 166.02

0.670

Glycine

969.6 ± 345.51

1028.4 ± 324.70

0.699

Asparagine

93.4 ± 64.70

89.4 ± 38.07

0.867

Aspartate

33.8 ± 28.98

27.1 ± 11.42

0.506

β-Alanine

40.2 ± 30.23

36.4 ± 29.41

0.778

Gluamine

1147.6 ± 610.83

1145.6 ± 443.26

0.993

Ornithine

129.2 ± 58.12

140.1 ± 54.79

0.670

Serine

157.5 ± 71.10

178.6 ± 73.07

0.523

Taurine

103.0 ± 48.11

133.4 ± 52.98

0.196

Phenylalanine

Tryptophan

103.7 ± 51.3
118.1 ± 45.68
0.518
Tyrosine
1
Diet 1 = a L-methionine supplemented diet; Diet 2 = a DL-methionine supplemented
diet. The calculated dietary standardized ileal digestible methionine contents in both Diets
1 and 2 were 0.37% (as-fed basis).
2
Each value is a Mean ± Standard deviation (n = 10).
3
P-values were obtained from Student T-test.
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Table 2.8

The mRNA expression of selected myogenesis genes by the pigs fed a Lor DL-methionine supplemented diet before and after the four week
feeding trial1
Dietary treatment

Gene Name
Before the feeding trial (d 0)

Gene Symbol

Diet 1

Diet 2

P-value2

Myogenic differentiation 1

MYOD1

0.79 ± 0.21

1.17 ± 0.73

0.140

Myogenin

MYOG

1.09 ± 0.42

1.34 ± 1.02

0.491

Myogenic factor 5

MYF5

0.71 ± 0.18

0.95 ± 0.47

0.162

Myogenic Regulator factor 4

MRF4

1.38 ± 0.48

1.74 ± 1.82

0.563

Myocyte enhancer factor 2A

MEF2A

4.36 ± 6.49

1.26 ± 1.07

0.193

Myocyte enhancer factor 2B

MEF2B

1.58 ± 0.61

1.58 ± 1.33

1.000

Myocyte enhancer factor 2C
Myocyte enhancer factor 2D,
transcript variant X1
After the feeding trial (d 28)

MEF2C
MEF2D

1.14 ± 0.44
1.58 ± 0.64

2.07 ± 2.72
2.35 ± 3.79

0.312
0.562

Myogenic differentiation 1

MYOD1

1.03 ± 0.25

1.08 ± 0.49

0.794

Myogenin

MYOG

1.22 ± 0.50

1.05 ± 0.98

0.660

Myogenic factor 5

MYF5

1.25 ± 0.06

1.12 ± 0.52

0.475

Myogenic Regulator factor 4

MRF4

1.30 ± 0.26

1.27 ± 1.05

0.940

Myocyte enhancer factor 2A

MEF2A

0.66 ± 0.22

0.90 ± 0.53

0.272

Myocyte enhancer factor 2B

MEF2B

0.53 ± 0.27

1.17 ± 1.19

0.175

Myocyte enhancer factor 2C
MEF2C
2.39 ± 0.48
1.69 ± 2.26
0.553
Myocyte enhancer factor 2D,
MEF2D
0.90 ± 0.44
1.12 ± 1.10
0.614
transcript variant X1
1
Diet 1 = a L-methionine supplemented diet; Diet 2 = a DL-methionine supplemented diet.
The calculated dietary standardized ileal digestible methionine contents in both Diets 1 and 2
were 0.37% (as-fed basis).
2
P-values were obtained from Student T-test.
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